+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound heterozygosity of two missense mutations in the NADH-cytochrome b5 reductase gene of a Polish patient with type I recessive congenital methaemoglobinaemia



Compound heterozygosity of two missense mutations in the NADH-cytochrome b5 reductase gene of a Polish patient with type I recessive congenital methaemoglobinaemia



European Journal of Haematology 70(6): 404-409



A case of type I methaemoglobinaemia observed in a Polish subject with compound heterozygosity for two mutations in the reduced nicotinamide adenine dinucleotide (NADH) cytochrome b5 reductase (b5R) gene is described. One is a novel mutation 647TfwdarwC which leads to substitution of isoleucine by threonine at position 215 (I215T). This maternal mutation was found in several family members. A previously known mutation, 757GfwdarwA, leads to the replacement of valine by methionine at position 252 (V252M). The latter mutation was found also in the father and one of the two brothers. The effects of these mutations were analysed on a model of the human b5R protein obtained by homology modelling. Although both amino acid substitutions are located in the NADH-binding domain, the whole protein structure, especially the region between the flavin adenine dinucleotide and NADH-binding domains, is disturbed. The structural changes in the I215T mutant are less prominent than those in the V252M mutant. We presume that the 647TfwdarwC mutation is a type I mutation, however, it has not been observed in the homozygous state.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010368903

Download citation: RISBibTeXText

PMID: 12756024

DOI: 10.1034/j.1600-0609.2003.00070.x


Related references

Recessive congenital methaemoglobinaemia type II, a new mutation which causes incorrect splicing in the NADH-cytochrome b-5 reductase gene. Journal of Inherited Metabolic Disease 20(4): 610, 1997

Prenatal diagnosis of recessive congenital methaemoglobinaemia type II: novel mutation in the NADH-cytochrome b5 reductase gene leading to stop codon read-through. European Journal of Haematology 74(5): 389-395, 2005

Molecular basis of recessive congenital methemoglobinemia, types I and II: Exon skipping and three novel missense mutations in the NADH-cytochrome b5 reductase (diaphorase 1) gene. Human Mutation 17(4): 348, 2001

NADH-cytochrome b5 reductase in a Turkish family with recessive congenital methaemoglobinaemia type I. Journal of Clinical Pathology 61(10): 1122-1123, 2008

Two new mutations in the NADH-cytochrome B5 reductase gene in families with recessive congenital methemoglobinemia type I. British Journal of Haematology 102(1): 10, July 1, 1998

Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II. Blood 85(8): 2254-2262, 1995

Severe mental retardation and recessive congenital methemoglobinemia in three Indian patients: compound heterozygous for NADH-cytochrome b5 reductase gene mutations. American Journal of Hematology 86(3): 327-329, 2011

Identification of three new mutations in the NADH-cytochrome b5 reductase gene responsible for recessive congenital methemoglobinemia type II. American Journal of Human Genetics 55(3 SUPPL ): A232, 1994

Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH-binding lobe of cytochrome b5 reductase. British Journal of Haematology 129(6): 847-853, 2005

Identification of a novel point mutation (Leu72Pro) in the NADH-cytochrome b5 reductase gene of a patient with hereditary methaemoglobinaemia type I. British Journal of Haematology 102(2): 575-577, 1998

A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia. Blood 95(10): 3250-3255, 2000

Molecular basis of hereditary methaemoglobinaemia, types I and II: Two novel mutations in the NADH-cytochrome b5 reductase gene. British Journal of Haematology 103(4): 922-930, 1998

A novel nine base deletion mutation in NADH -cytochrome b5 reductase gene in an Indian family with recessive congenital methemoglobinemia-type-II. Molecular Genetics and Metabolism Reports 5: 44-47, 2015

Identification of causative mutations and prenatal diagnosis for hereditary methaemoglobinaemia due to type II NADH cytochrome B5 reductase deficiency. British Journal of Haematology 86(SUPPL 1): 7, 1994

A novel G143D mutation in the NADH-cytochrome b5 reductase gene in an Indian patient with type I recessive hereditary methemoglobinemia. Blood Cells, Molecules and Diseases 40(3): 323-327, 2007